Navigation Links
ASGE issues updated guidelines on antibiotic prophylaxis for gastrointestinal endoscopy
Date:5/13/2008

OAK BROOK, Ill. May 13, 2008 The American Society for Gastrointestinal Endoscopy (ASGE) has issued updated guidelines on antibiotic prophylaxis for gastrointestinal (GI) endoscopy based on the American Heart Associations (AHA) recently revised guidelines for prophylaxis of infective endocarditis (IE). For endoscopic practice, the administration of prophylactic antibiotics solely to prevent IE is not recommended for patients who undergo GI-tract procedures. The updated ASGE guidelines reflect that change. The guidelines appear in the May issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the ASGE.

The purpose of antibiotic prophylaxis during GI endoscopy is to reduce the risk of significant endogenous infectious complications. The guidelines, prepared by the ASGE Standards of Practice Committee, note that clinically significant infections after endoscopic procedures are extremely rare. Bacteria may enter into the bloodstream during an endoscopy for a variety of reasons including microscopic tears in the bowel related to the procedure. Endoscopy-related bacteremia carries a small risk of localization of infection in remote tissues (i.e., infective endocarditis, an infection of the lining of the heart cavities and connective tissue). An endoscopy may also result in local infections in which a typically sterile space or tissue is breached and contaminated by an endoscopic accessory or by contrast injection.

Clinically significant infections from an endoscopic procedure are extremely rare. Despite an estimated 14.2 million colonoscopies and 2.8 million flexible sigmoidoscopies, and perhaps as many upper endoscopies, performed in the United States each year, only approximately 15 cases of IE have been reported, with a temporal association with an endoscopic procedure, said Todd H. Baron, MD, FASGE, chair of the ASGE Standards of Practice Committee. There are no data that demonstrate a causal link between e
'/>"/>

Contact: Anne Brownsey
abrownsey@asge.org
630-570-5635
American Society for Gastrointestinal Endoscopy
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products
2. Fourth Annual Games for Health Conference Joins Health and Gaming Innovators to Discuss Next-Generation Game Technologies and Health Issues
3. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
4. American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists
5. Patient Safety Authority Issues Annual Report for 2007
6. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc.
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc.
8. Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute
9. Courage Center Offers Credentialed Educational Forum on Issues of Returning Injured Employees to Work
10. The Womens Health II Medical Education Network Raises Awareness About the Diagnosis and Management of Womens Health Issues
11. National Business Coalition on Health Issues Value-Based Purchasing Report at 5th Annual World Health Care Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...ELEY, Calif., Nov 20 A new study b...itionquest.com ) and Kaiser Division of Research,...mailed health promotion,program, "Alive!" signifi... The researchers also found improvement in "p...motional problems interfere with productivity and ...
(Date:11/20/2008)... CITY, Utah, Nov. 20 Nut...UTR ) today reported results for the fiscal,2008 ..., Net sales for the fiscal 2008 fourth quar...for the same quarter of fiscal 2007. For the four...llion, or $0.14 diluted earnings per,share, compa...
(Date:11/20/2008)...OVIA, Calif., Nov. 20 ST...unced the creation of a team of leading ophthalmic...Team), to work with the,Company in a collaborativ...s,of its Collamer lens technology. Accommodating ...designed to restore the eye,s ability to "accommod...
(Date:11/20/2008)...HFIELD, Ill., Nov. 20 T...d accreditation authority, is pleased to announce ... Piedmont Medical Laboratory . This accreditation...andardization (ISO) for laboratory technical compe... on improved patient safety and risk reduction, ou...
Breaking Medicine News(10 mins):Health News:NutritionQuest's Alive! Program Improves Quality of Life 2Health News:Nutraceutical Reports 2008 Fiscal Year End Results 2Health News:Nutraceutical Reports 2008 Fiscal Year End Results 3Health News:Nutraceutical Reports 2008 Fiscal Year End Results 4Health News:Nutraceutical Reports 2008 Fiscal Year End Results 5Health News:Nutraceutical Reports 2008 Fiscal Year End Results 6Health News:Nutraceutical Reports 2008 Fiscal Year End Results 7Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 2Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 3Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 4Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 5Health News:Accreditation to the International Standards Organization for Quality Management Granted to First U.S. Lab 2Health News:Accreditation to the International Standards Organization for Quality Management Granted to First U.S. Lab 3
...chers at the University of Illinois at Chicago and...o re-activate silenced genes in patients who suffe...ing and after a stroke, certain cellular events ta...rain cells. Compounds that inhibit a group of enzy...
...enience of high heels has so far been restricted o...or soreness, but a new study has revealed that hi...r 12 million women. The study called stilettos an... for driving and said that women are actually risk...
...randum of Agreement was signed today between the N...W) and National Research Development Corporation (... NIHFW in the fields of Thermo Stable Elisa Kits a...he up scaling of technologies developed by the Ins...
...rld Health Organization (WHO) announced that it is...on plans to create a global stockpile of vaccine ...ent follows a request by the World Health Assembly...blish an international stockpile of H5N1 vaccine. ...
Other Medicine News:Health News:Researchers Developing New Therapy to Re-activate Silenced Genes 2Health News:National Institute Of Health & Family Welfare To Commercialize Its Products 2
(Date:11/19/2008)...rs $5 Million Payment from Roche- , , MONTV...y Pharmaceuticals Corp. (Nasdaq: MEMY ) today an...or its Phase 2 trial of R3487/MEM 3454, its lead a...pairment associated with schizophrenia (CIAS). Th... 2 trial, triggering a $5.0 million payment from i...
(Date:11/18/2008)...NE, Va., Nov. 18 Forty-...red at a November national forum to consider cutti...ic health and national economy from outbreaks of d...ced today. , , Among those innovations: , ...American kitchen table that detects highly contagi...
(Date:11/13/2008)... Study Suggests Nutritional Supplements Prior to S...ire-USNewswire/ -- Identifying,malnutrition before...ody,contouring will significantly decrease surgica... scar quality and boost patient energy levels,acc... and Reconstructive,Surgery(R), the official medic...
(Date:11/12/2008)...VELAND, Ohio and LOD, Israel, November 12 /PRNewsw...dical Center, NY indicated that,patient-specific C...tor,(ANGIO Mentor(TM), Simbionix US) with high fac...e simulation improved the operative flow,increase... decreased,overall operative and fluoroscopy time ...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Robert Bonow MD Honored for Outstanding Service by the American College of Cardiology 15675 1Robert Bonow MD Honored for Outstanding Service by the American College of Cardiology 15675 2Robert Bonow MD Honored for Outstanding Service by the American College of Cardiology 15675 3Effectively Influencing the Hospital Marketplace to Win a Place on Formularies 15672 1Effectively Influencing the Hospital Marketplace to Win a Place on Formularies 15672 2Easter Seals Notes Aprils Autism Awareness Month to Highlight Services Available to Families Living With Autism 15669 1Easter Seals Notes Aprils Autism Awareness Month to Highlight Services Available to Families Living With Autism 15669 2Easter Seals Notes Aprils Autism Awareness Month to Highlight Services Available to Families Living With Autism 15669 3Reps Smith and Doyle Autism Society of America Push Landmark Legislation on World Autism Awareness Day 15666 1Reps Smith and Doyle Autism Society of America Push Landmark Legislation on World Autism Awareness Day 15666 2Reps Smith and Doyle Autism Society of America Push Landmark Legislation on World Autism Awareness Day 15666 3
... - MGI Pharma, Inc.,(Nasdaq:MOGN), a biopharmaceut...oday provided highlights of data presentations mad...ology (ASCO) Annual,Meeting. Dacogen (decitabine) ...uding the presentation of efficacy data in older,p...activity,observed in patients with refractory acut...
...n 5, 2007 - Javelin,Pharmaceuticals, Inc. (AMEX: J...n control, today announced that its Phase 2,multi-...ine, the,official journal of The American Academy ...c Efficacy and Safety of,Morphine-Chitosan Nasal S...ollowing Orthopedic Surgery", was recently made,av...
Other Medicine Technology:MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine),Data Published in Pain Medicine 2Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine),Data Published in Pain Medicine 3
Sterile Bad-Parker blades offer the superior cutting advantages of carbon and stainless steel technology, plus the exclusive Rib-Back design for greater cutting control and strength. Brad-Parker bran
BD Beaver implant blade, 5.1 mm, angled 45, bevel up. matte finish. Designed for widening the incision for lens implantation. Beaver implant blades put precision and control in your hands, sterile.
BD Beaver Meniscus blade, 7 mm flat (4/bx, 1 bx/ca), specially designed maximum leverage and visibility, cutting edge: 7 mm, sterile.
... made of optical quality acrylic and are lightweig... sets available providing a full range of prisms. ...nt can wear the prism with the trial frame while i...use of the prism. Patient feedback will be much be...
Medicine Products: